0001209191-23-058855.txt : 20231215 0001209191-23-058855.hdr.sgml : 20231215 20231215175523 ACCESSION NUMBER: 0001209191-23-058855 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231214 FILED AS OF DATE: 20231215 DATE AS OF CHANGE: 20231215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lowrance David L CENTRAL INDEX KEY: 0001408498 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32157 FILM NUMBER: 231491621 MAIL ADDRESS: STREET 1: 422 WILLIAM WALLACE DRIVE CITY: FRANKLIN STATE: TN ZIP: 37064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Savara Inc CENTRAL INDEX KEY: 0001160308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841318182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6836 BEE CAVE ROAD STREET 2: BUILDING 3, SUITE 201 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 51285113796 MAIL ADDRESS: STREET 1: 6836 BEE CAVE ROAD STREET 2: BUILDING 3, SUITE 201 CITY: AUSTIN STATE: TX ZIP: 78746 FORMER COMPANY: FORMER CONFORMED NAME: Mast Therapeutics, Inc. DATE OF NAME CHANGE: 20130312 FORMER COMPANY: FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030613 FORMER COMPANY: FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010928 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-14 0 0001160308 Savara Inc SVRA 0001408498 Lowrance David L ONE SUMMIT SQUARE, 1717 LANGHORNE NEWTOWN ROAD, SUITE 300 LANGHORNE PA 19047 0 1 0 0 CHIEF FINANCIAL OFFICER 0 Common Stock 2023-12-14 4 F 0 30438 4.45 D 212355 D Common Stock 2023-12-14 4 A 0 160000 0.00 A 372355 D Common Stock 2023-12-15 4 G 0 20000 0.00 D 352355 D Stock Option (Right to Buy) 4.45 2023-12-14 4 A 0 40000 0.00 A 2033-12-14 Common Stock 40000 40000 D Represents shares withheld by the Issuer in connection with the reporting person's net share settlement to satisfy tax liability based upon the vesting of previously awarded restricted stock units. Represents restricted stock units ("RSUs") that vest in full on December 14, 2025, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The reporting person made a bona fide gift to The McCallie School. The reporting person does not have voting or investment power with respect to the shares held by The McCallie School. The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 14, 2023, subject to the reporting person's continued service with the Issuer. /s/ David Lowrance 2023-12-15